Clinical Trial Update: The Effects of Orexin Antagonism on Fear Extinction in PTSD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether orexin antagonism affects fear extinction in post-traumatic stress disorder, with insomnia as a co-morbid condition; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Post-traumatic Stress Disorder

Drugs mentioned

• Orexin receptor antagonist

Snippet

Sponsor: VA Office of Research and Development | Conditions: Insomnia, PTSD | Phase 4 | Status: NOT_YET_RECRUITING